Medtronic exclusive reactive ATP(TM) therapy slows progression of atrial fibrillation
Medtronic announced that its Reactive ATP(TM) therapy slows the progression of AF in patients with implanted cardiac devices. The Reactive ATP(TM) therapy repeatedly sends pacing pulses to the atria during abnormally fast rhythms to restore the heart's normal rhythm. June 18, 2017